Articles published by Pacira BioSciences
Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
October 03, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
September 09, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Pacira to Report 2023 Financial Results on Thursday February 29, 2024
February 22, 2024
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Pacira Appoints Frank D. Lee as Chief Executive Officer
December 21, 2023
From Pacira BioSciences
Via GlobeNewswire
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
November 10, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
November 07, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Pacira BioSciences Reports Third Quarter 2023 Financial Results
November 02, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
October 12, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
October 10, 2023
From Pacira BioSciences
Via GlobeNewswire
Tickers
PCRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.